<DOC>
	<DOCNO>NCT00706719</DOCNO>
	<brief_summary>The study design determine Androxal® would affect sperm parameter ( count , concentration , volume ) men secondary hypogonadism previously treat topical testosterone .</brief_summary>
	<brief_title>To Evaluate Sperm Parameters Men With Secondary Hypogonadism Previously Treated With Topical Testosterone</brief_title>
	<detailed_description>The study design determine Androxal® would affect sperm parameter ( count , concentration , volume ) men secondary hypogonadism previously treat topical testosterone . A maximum twelve subject per group randomize daily treatment Androxal® topical testosterone ( Testim® ) six month . The protocol later amend include treatment group receive Androxal 3 month wash period .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<criteria>Healthy adult male 21 60 year age diagnose AIHH . Subjects must treat topical testosterone replacement therapy ( typically AndroGel® Testim® ) least 6 month enrollment 2 year . A history idiopathic infertility due primary hypogonadism , testicular failure , Kallmann 's syndrome infertility condition . Subjects demonstrate clinically significant medical condition render subject infertile marginally fertile AIHH . Men history , know , suspect prostate disease rule prostate biopsy , prostate specific antigen ( PSA ) &gt; 3.6 clinical suspicion current prostate disease . Men hematocrit excess 50 % hemoglobin &gt; 17 g/dl</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Adult Onset Idiopathic Hypothalamic Hypogonadism ( AIHH )</keyword>
	<keyword>Secondary hypogonadism</keyword>
	<keyword>Semen volume</keyword>
	<keyword>Sperm count</keyword>
	<keyword>Sperm motility</keyword>
</DOC>